Drug Database
Back to search

Netherlands· NL-c810270db7aa

Normosang 25 mg/ml, concentraat voor oplossing voor infusie

A hemin product containing humaan hemine, registered in Netherlands by Recordati Rare Diseases. The same ATC class is registered in 11 of our 19 countries.

ATC B06AB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNormosang 25 mg/ml, concentraat voor …ATCB06AB01REGISTER NO.NL-c810270db7aaPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about humaan hemineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hemin is registered in 11 of 19 countries.

Countries holding a registration under ATC B06AB01 (hemin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search hemin products by name

Hemin · ATC B06AB01

11 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HUMAAN HEMINE
Manufacturer
Recordati Rare Diseases
Country
Netherlands (NL)
ATC code
B06AB01
ATC class
Hemin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    33614

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

90 interactions on record for hemin.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hemin against other medicinesHow interaction checks work

Hemin · interactions on record

90 records

  • 21 severe
  • 69 moderate

Most severe, free to view

  • EstradiolD11AX34severe
  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B06AB01

Hemin, as other registers publish it.

All hemin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/368acaf5-d21b-4612-b85d-fad5ddbb36e3
GET /v1/drugs/368acaf5-d21b-4612-b85d-fad5ddbb36e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h33614_smpc.pdf",
  "strength": null,
  "atc_label": "Hemin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg33614",
  "excipients": [
    "ARGININE, (L-)",
    "ETHANOL 96 %",
    "PROPYLEENGLYCOL (E 1520)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HUMAAN HEMINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h33614.pdf",
  "authorised_at": "2008/12/11",
  "procedure_number": "FR/H/0140/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "33614",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about hemin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console